Lexicon Pharmaceuticals LXRX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $69.64M+123% | $49.8M+60.2% | $70.86M+1,255% | $58.43M+1,505% | $31.21M+1,251% | ||
| $352K-42.8% | $274K-55.5% | $421K+24.6% | $482K+75.9% | $615K+430% | ||
| $69.29M+126% | $49.53M+62.6% | $70.44M+1,340% | $57.95M+1,621% | $30.6M+1,294% | ||
| 99.5%+1.5pp | 99.4%+1.4pp | 99.4%+5.9pp | 99.2%+6.7pp | 98%+3.0pp | ||
| $58.58M-31.4% | $61.12M-27.6% | $76.49M+5.4% | $83.52M+29.8% | $85.41M+39.5% | ||
| $34.94M-71.5% | $37.32M-73.9% | $60.82M-57.6% | $92.81M-31.8% | $122.65M-3.4% | ||
| $93.87M-55.0% | $98.71M-56.7% | $137.73M-36.3% | $176.81M-11.9% | $208.68M+10.8% | ||
| -$24.23M+86.3% | -$48.91M+75.2% | -$66.87M+68.3% | -$118.37M+39.9% | -$177.46M+4.6% | ||
| -34.8%+534pp | -98.2%+536pp | -94.4%+3,943pp | -202.6%+5,210pp | -568.6%+7,477pp | ||
| $6.84M-45.9% | $8.33M-35.5% | $9.77M-19.7% | $11.3M-11.7% | $12.63M+9.9% | ||
| $6.23M-50.7% | $6.91M-43.8% | $8.46M-28.7% | $10.33M-9.6% | $12.63M+47.1% | ||
| —— | —— | —— | —— | —— | ||
| -$26.09M+85.3% | -$50.34M+74.9% | -$68.58M+68.3% | -$120.62M+40.3% | -$177.3M+8.4% | ||
| -37.5%+531pp | -101.1%+544pp | -96.8%+4,042pp | -206.4%+5,344pp | -568%+7,809pp | ||
| -$0.07+86.3% | -$0.14+78.1% | -$0.19+74.7% | -$0.33+57.7% | -$0.51+38.6% | ||
| -$23.67M+86.6% | -$48.29M+75.4% | -$66.24M+68.5% | -$117.77M+40.1% | -$176.9M+4.6% | ||
| -34%+533pp | -97%+536pp | -93.5%+3,933pp | -201.6%+5,195pp | -566.7%+7,454pp | ||
| -$24.23M+86.3% | -$48.91M+75.2% | -$66.87M+68.3% | -$118.37M+39.9% | -$177.46M+4.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Lexicon Pharmaceuticals's revenue?
- Lexicon Pharmaceuticals (LXRX) generated $69.6M in revenue over the trailing twelve months, up 123.1% year over year.
- Is Lexicon Pharmaceuticals profitable?
- Lexicon Pharmaceuticals is not currently profitable: it reported a net loss of $26.1M over the trailing twelve months, a -37.5% net margin.
- What are Lexicon Pharmaceuticals's profit margins?
- Gross margin is 99.5% and operating margin is -34.8%, with a -37.5% net margin.
- What is Lexicon Pharmaceuticals's earnings per share?
- Lexicon Pharmaceuticals's diluted EPS over the trailing twelve months is $-0.07.
- Where does Lexicon Pharmaceuticals's income statement data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
